Technology Development Center
The ApiJect Technology Development Center in greater Orlando, Florida is focused on helping pharmaceutical companies prepare their drug product for high-speed, high-volume production in a new type of scalable prefilled syringe that is made largely using the Blow-Fill-Seal aseptic process.
Expertise and Machinery
Our Experienced Industry Leaders
- In-house expertise in BFS manufacturing and device design/engineering with the ability to rapidly provide proof-of-concept and small-scale manufacturing.
- BFS experts, device engineers, computer numerical control (CNC) machinists, and scientists, each with at least 15 years of field-related experience.
Our Best-in-Class Machines and Utilities
- Machine shop with Hurco® 3-axis milling machines for prototype BFS mold design and production.
- Weiler Lab+ BFS machine for small-scale BFS evaluations (<5,000 containers per hour).
- Rommelag® 434 BFS machine for medium-scale BFS evaluations (>5,000 containers per hour).
Planned Future Expansion
The ApiJect Technology Development Center is expanding from its existing 16,000 square feet footprint to a 32,000 square feet freestanding facility. This expansion provides additional infrastructure space to further ongoing research and development, as well as to better support our pharma partners’ device development efforts.
Unlocking Blow-Fill-Seal for Prefilled Injectables
The ApiJect Platform is a device design and manufacturing process that can make scalable, prefilled, single-dose formats for a wide-range of biologics and other sterile pharmaceutical liquids. By bringing together a prefilled BFS container with a push-attach Needle-Hub – or other drug delivery system – the pharma partner receives all the manufacturing efficiency and scale benefits of the aseptic BFS process with convenience and simplicity of a prefilled injector.
Harnessing the Scale and Economics of Blow-Fill-Seal
Blow-Fill-Seal (BFS) is a globally-trusted aseptic packaging technology where the pharmaceutical grade plastic container is made, filled with the liquid drug product, and sealed in a rapid, continuous process. One larger BFS machine is able to fill-finish up to 15MM doses a month.
